Clinical Trial Update: Cancer Associated Thrombosis and Isoquercetin (CATIQ) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for Cancer Associated Thrombosis and Isoquercetin (CATIQ) completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Isoquercetin (isoquercetin)

Snippet

Sponsor: Jeffrey Zwicker, MD | Conditions: Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-11-12